Claim and evidence Close ×
Isomorphic Labs' January 2024 release describes the company as "an autonomous subsidiary of Alphabet that was launched from Alphabet's DeepMind in 2021" and says that it operates autonomously within Alphabet with its own dedicated resources. Copy claim link
Copy claim reference
Machine-checked, not reviewed by an editor Stated in source Supported
Supporting evidence: primary · 2 sources
Provision Statement · provision ID labs-iso-alphabet-subsidiary-2024 Date 2024-01-07 · publication Records dated 2024 → Scope and limits The company's self-description. No ownership share, control right or legal structure is recorded beyond these words; the same boilerplate appears in the Lilly release of the same date.
The evidence 02 primary source Supports the claim
Isomorphic Labs announces strategic multi-target research collaboration with Novartis ↗ Isomorphic Labs · 2024-01-07
Copy source reference
Cite the original source Cite the original document, not Selekoa. Check these details against it.
Copy APA
Download BibTeX Download RIS Download CSL-JSON
Source excerpt “Isomorphic Labs is an autonomous subsidiary of Alphabet that was launched from Alphabet's DeepMind in 2021” Location in source PDF p. 1, "About Isomorphic Labs"
How it was read Retrieved directly from the publisher
Machine-checked · 2026-10-30
Source details and check notes Authors Isomorphic Labs Version Retrieved for the candidate pack on 2026-10-30 (SHA-256 e1c6975d8c71adee0d87242b349ac3c567adbb78902c747876e8156ffc748eac). PDF news release dated January 7, 2024, linked from the Isomorphic Labs article of that date; retrieved 2026-10-30. Its wording can change; earlier wording is not authenticated. Canonical address Open the canonical source ↗ Accessed 2026-10-30 Language English (en) Attribution Isomorphic Labs, “Isomorphic Labs announces strategic multi-target research collaboration with Novartis”, 2024-01-07. Reuse No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution. Check notes Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (16 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. No human editorial review. primary source Supports the claim
Isomorphic Labs announces strategic multi-target research collaboration with Lilly ↗ Isomorphic Labs · 2024-01-07
Copy source reference
Cite the original source Cite the original document, not Selekoa. Check these details against it.
Copy APA
Download BibTeX Download RIS Download CSL-JSON
Paraphrase The Lilly release of the same date states that the company operates autonomously within Alphabet with its own dedicated resources and an exclusive focus on applying AI to drug discovery.
Location in source PDF p. 1, fifth paragraph
How it was read Retrieved directly from the publisher
Machine-checked · 2026-10-30
Source details and check notes Authors Isomorphic Labs Version Retrieved for the candidate pack on 2026-10-30 (SHA-256 b98516157887ccc70377a9e83bccf3caec3de1dfa3838bfe63719cde10092b4b). PDF news release dated January 7, 2024, linked from the Isomorphic Labs article of that date; retrieved 2026-10-30. Its wording can change; earlier wording is not authenticated. Canonical address Open the canonical source ↗ Accessed 2026-10-30 Language English (en) Attribution Isomorphic Labs, “Isomorphic Labs announces strategic multi-target research collaboration with Lilly”, 2024-01-07. Reuse No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution. Check notes Candidate pack passage, AI in biology (research/ai-in-biology). The paraphrase is Selekoa’s, written from the text retrieved for the candidate pack on 2026-10-30; it is not a quotation and was not machine-matched. No human editorial review. Status and meaning Editorial status. Not reviewed by an editor . An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.
Relation. An exact framework edition, or another document with an exact expression, states one provision: a capability threshold or risk level and its trigger, a required safeguard or action, a decision authority (who decides, recommends, can overrule or is informed), a stated exception, or another statement of its content, such as a licence term or a prospectus statement. The passage records what the document says, not implementation, compliance or effectiveness. Provisions with the same key align across editions of one family.
Date. Dated by the release. The record is dated by the text’s date of publication, which is the date of its announcement.
Record ID aib-labs-iso-alphabet-subsidiary-2024